Loading
Loading…
Loading…
| # | Schedule | Awarded To | Bids | Value |
|---|---|---|---|---|
| 1 | Schedule 1 | NUTRAKEM PHARMA | 1 | ₹52,500 |
| 2 | Schedule 2 | NUTRAKEM PHARMA | 1 | ₹89,200 |
| 3 | Schedule 3 | NUTRAKEM PHARMA | 1 | ₹22,000 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
13 Aug 2025, 11:00 amClosed
L-carnitine 340mg
Ubidecarenone 50mg
Zinc 5mg
Lycopene 2.5mg and Astaxanthin 8mg (340+ 50+ 5+
CAPSULE Cod liver oil 300MG
Evening primrose oil 300MG
Omega-3 fatty acid 90MG and Vitamin E 10MG
8099250
GEM/2025/B/6461589
Two Packet Bid
L-carnitine 340mg, Ubidecarenone 50mg, Zinc 5mg,
90 days
323307, Contracts & Material Management, RAPS Hospital PO-Bhabha Nagar Rawatbhata Via-Kota Rajasthan Which is about 50 Kms. away from Kota.
Item wise evaluation
PRODUCT_CUSTOM
2 documents required · 2 mandatory
Exempted
20 Aug 2025
22 Jul 2025
13 Aug 2025
L-carnitine 340mg
Ubidecarenone 50mg
Lycopene 2.5mg and Astaxanthin 8mg (340+ 50+ 5+
CAPSULE Cod liver oil 300MG
Evening primrose oil 300MG
Omega-3 fatty acid 90MG and Vitamin E 10MG
L-carnitine 340mg
Ubidecarenone 50mg
Lycopene 2.5mg and Astaxanthin 8mg (340 + 50 + 5 + 2.5 + 8 mg) ALL STRENGTH
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8099250.pdf
GEM_BID
cust-83985-1_2025-07-17-09-14-40_d22fe7bbab390be07f23decafc3438a3.pdf
SPECIFICATION
cust-83985-2_2025-07-17-09-17-30_476ab894d310dbf5e33d24f695f81d28.pdf
SPECIFICATION
cust-83985-3_2025-07-17-09-19-10_d708730c54ac171ee452b24e9e334c27.pdf
SPECIFICATION
ANNXEBLW_53b90e8f-5eae-493a-919e1752724936609_Assistant30.doc
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .